Daniel from Improve Press
Between 30% to 50% of most cancers circumstances are preventable, in response to the World Well being Group. Precluding the development of most cancers can save sufferers and payers cash and result in a greater high quality of life.
Feyi Ayodele, founder and CEO at CancerIQ, sat down with MobiHealthNews to debate CancerIQ’s choices and the way healthcare organizations use its know-how to detect and thwart the acceleration of most cancers in sufferers prone to the illness.
MobiHealthNews: Are you able to inform our viewers about CancerIQ?
Feyi Ayodele: CancerIQ is an organization on a mission to actually increase entry to the newest improvements in most cancers prevention, early detection and therapy.
MHN: And the way does it try this?
Ayodele: We try this by ensuring we’re actually absolutely integrating genomic drugs into routine care. The extra we study concerning the relationship between most cancers and our genes and different components because the science evolves, we should always have the ability to act on that information. Basically, what we do is we make it in order that your on a regular basis supplier can use that info and design a personalised care plan.
MHN: What position does digital well being play in your providing?
Ayodele: So how we have performed it really goes again to type of a founding story. So, I began this firm after working with my mom, who’s a world-renowned breast medical oncologist and most cancers geneticist on the College of Chicago, which is de facto one of many founding members of this preventive oncology program.
And what I acknowledged as she was making an attempt to scale this program past the College of Chicago into their associates is that a whole lot of the associates stated they did not have the time, they did not have the information, and, you already know, they finally did not have the assets to do issues the way in which my mom was doing issues on the College of Chicago.
So, I type of work with the consultants within the subject … to automate and digitize a whole lot of the method of preventive oncology, beginning up entrance with automating the household historical past knowledge assortment, a whole lot of stuff you gather from sufferers in order that we’re saving suppliers time in gathering info to resolve the information situation.
We’re actually a content material engine that has the entire newest, most cutting-edge medical tips and serves these up for suppliers and sufferers. And likewise automating the continuing administration course of. My mom had a full staff of navigators that type of known as sufferers that had been at elevated danger, ordered their MRIs, adopted up with them as a result of they should do one thing that is much more time intensive than different populations, and we have automated that course of as effectively.
So basically, we have taken a medical service and we digitized it, which is, I believe, the definition of digital well being.
MHN: How are healthcare methods utilizing CancerIQ’s choices?
Ayodele: One of many first issues that they are utilizing CancerIQ to do is to actually increase the genetic service or launch a genetic service.
So, they’re placing our software program within the fingers of the suppliers who could also be skilled to do that already, and thru that course of automation, they had been capable of double their service capability or increase it to extra sufferers. In order that’s a method that well being methods are utilizing it.
The opposite manner that well being methods are utilizing it’s they’re really absolutely counting on CancerIQ to launch that new service inside their group. So we’re increasing the genetics workforce by really giving our software program to suppliers who aren’t skilled in genetics and thru automation and once more, that the content material that we have by it, we will flip your on a regular basis supplier into that MacArthur Genius award-winning medical oncologist like my mother.
MHN: How does CancerIQ enhance entry to genetic testing?
Ayodele: The way in which CancerIQ is increasing entry is we’re basically offering a extra high-resolution view of a affected person inhabitants. So suppliers know these ones that want genetic testing want one thing above and past the usual of care as a result of in the event that they appropriately establish these sufferers, they’re actually low-cost methods for sufferers to entry these providers.
MHN: What’s in retailer for 2024?
Ayodele: So, in 2024, we’re capitalizing on a few actually robust headwinds for CancerIQ.
There’s been some current information about how ASCO [American Society of Clinical Oncology] has modified its tips and made it so that everyone with breast most cancers ought to get genetic testing. What does that imply? That implies that extra sufferers are going to get entry, and we’ll discover extra mutation carriers this yr than we ever have.
The second factor that is actually thrilling for CancerIQ is that there is rising consciousness of those later-stage youthful sufferers who’re getting most cancers.
So, for 2024, a whole lot of what CancerIQ is concentrated on isn’t just getting folks entry to testing or figuring out them in danger however really actually deeply investing in the way in which that we handle these sufferers at elevated danger as a result of we’ll have a inhabitants of mutation carriers and high-risk sufferers that’s most likely the biggest inhabitants this well being system has ever needed to handle.
And I believe by investments in our software program, we’re going to have the ability to amplify the efforts of each clinician and ensure these sufferers keep on monitor and keep forward of most cancers.
Basically, what we’re doing is giving everybody a hyper-personalized most cancers prevention plan. I might say that is type of the layperson’s view of this. Genetic testing is simply one of many issues that will get performed within the CancerIQ workflow, however we’re not a genetic testing lab. In actual fact, we most likely course of extra assessments than a number of the genetic testing labs which might be on the market with out really proudly owning a lab in any respect.
We’re really within the enterprise of decoding this info, ensuring it is attending to sufferers and is really of their fingers so that every one affected person populations can actually act on the data versus simply getting examined by itself.
